Le Lézard
Classified in: Health
Subjects: LAW, AVO

East End Resident with Autism Alleges Fair Housing Complaint Against Southampton Landlord, US Autism Homes


Complaint Alleges Retaliatory and Constructive Eviction, Discrimination under ADA

SOUTHAMPTON, N.Y., Oct. 8, 2023 /PRNewswire-PRWeb/ -- Donus v. US Autism Homes Inc. (2:23-cv-05838) was filed by Christian Killoran, attorney, on behalf of client, Dimitri Donus, a congenial 21-year-old man with autism after he was evicted 6 months early from his rental unit in Southampton, NY. According to Dimitri's parents, Dimitri was evicted after they raised concerns about his overnight safety, the home's appropriation of his government-issued funds, and requested a reasonable accommodation.

US Autism Homes brands itself as a "faith-based" not-for-profit utilizing a non-certified housing model, a term in the NYS OPWDD portfolio of services allowing qualified participants to receive a housing subsidy while self-directing additional individualized services. "Non-certified housing is not what's commonly known as a group home. It's simply a Landlord leasing a unit to a tenant who happens to have a disability. USAH claims to operate housing and seems to have a list of mandated non-published rules as a condition for tenancy, most of which are an infraction of Fair Housing regulations" according to Mr. Killoran. The complaint also raises questions surrounding ADA, retaliatory eviction, and constructive eviction.

The complaint, filed on August 1, alleges that the Landlord commandeered Dimitri's benefits including a requirement to attend community classes designed by the Landlord, utilization of their leadership team to control his staff, adherence in following a uniform schedule, and adoption of a meal plan without his input. In addition, it alleges that the Landlord orchestrated Dimitri's eviction because he profiles as a disabled person who became unwilling to allow his budget of services commandeered in a manner desired by them.

According to a sworn affidavit signed by the Landlord, justification to terminate a tenant's lease is not required. The affidavit also states that the house operates under a collaborative model, not mentioned as a requirement in his lease. Specifically, the affidavit referenced that Dimitri, who relies on his family for transportation, was often late to return to his rental unit after spending time with family or at appointments and that he neglected to pay for food for 6 months.

Dimitri also has 2 brothers with autism and is a whiz at folding pizza boxes. On Saturdays, when living at his rental unit in Southampton, he could be found at his volunteer job at Slice of the Hamptons.

The complaint, case #:2:23-cv-05838, is overseen by the US District Court for the Eastern District of NY (Nature of Suite/Civil Rights - Housing/Accommodations, Cause of Action - 42:405 Fair Housing Act)

Media Contact

Melanie Donus, Your Choice Consulting, 1 5164171108, [email protected], None

SOURCE Your Choice Consulting


These press releases may also interest you

at 04:45
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: